prof. dr. Nanja van Geel

Journal Article
A1
open access

Exploring the severity strata of disease activity and repigmentation in vitiligo based on validated Physician Global Assessment (PGA) scores

Nanja van Geel (UGent) , Liesbeth Delbaere (UGent) , Laura Mertens, Virginie Vandaele, Lien Depaepe, Jérôme Van Causenbroeck, Sofie De Schepper (UGent) , Laura Van Coile (UGent) , Astrid Van Reempts, Ann-Sophie De Vos, et al.

(2024) JOURNAL OF CLINICAL MEDICINE. 13(9).

Add to list

Conference Paper
C3
open access

SA-VES : a valid, reliable and feasible tool to assess patient perspective on vitiligo extent

Zoë De Schryver (UGent) , Liesbeth Delbaere (UGent) , Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) Belgian Dermatology Days 2024, Abstracts.

Add to list

Beyond visual inspection : the value of infrared thermography in skin diseases, a scoping review

Reinhart Speeckaert (UGent) , Isabelle Hoorens (UGent) , Jo Lambert (UGent) , Marijn Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 38(9). p.1723-1737

Add to list

A meta-analysis of the placebo response in vitiligo : causes and consequences for the interpretation of clinical trials

Reinhart Speeckaert (UGent) , Marijn Speeckaert (UGent) and Nanja van Geel (UGent)

(2024) PIGMENT CELL & MELANOMA RESEARCH. 37(1). p.74-80

Add to list

Journal Article
A1
open access

The impact of antioxidants on vitiligo and melasma : a scoping review and meta-analysis

Reinhart Speeckaert (UGent) , Vedrana Bulat, Marijn Speeckaert (UGent) and Nanja van Geel (UGent)

(2023) ANTIOXIDANTS. 12(12).

Add to list

Conference Paper
C3
open access

Exploring immune checkpoint proteins : novel targets in vitiligo research

Arno Belpaire (UGent) , Nanja van Geel (UGent) , Annelies Demeyer (UGent) and Reinhart Speeckaert (UGent)

(2023) 32nd EADV Congress, Abstracts.

Add to list

Journal Article
A1
open access

A meta-analysis of chemokines in vitiligo : recruiting immune cells towards melanocytes

Reinhart Speeckaert (UGent) , Arno Belpaire (UGent) , Marijn Speeckaert (UGent) and Nanja van Geel (UGent)

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Clinician‐reported outcome measures for the assessment of vitiligo : a scoping review

Nanja van Geel (UGent) , Jolien Duponselle (UGent) , Liesbeth Delbaere (UGent) , Sandrine Herbelet (UGent) , Viktoria Eleftheriadou, Khaled Ezzedine, Maxine Forman, Amit Garg, Iltefat H. Hamzavi, Julien Seneschal, et al.

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(11). p.2231-2242

Add to list

Conference Paper
C3
open access

Prognostic value of the vitiligo disease activity signs

Liesbeth Delbaere (UGent) , Jolien Duponselle (UGent) , Sandrine Herbelet (UGent) , Reinhart Speeckaert (UGent) and Nanja van Geel (UGent)

(2023) Belgian Dermatology Days 2023, Abstracts.

Add to list

Journal Article
A1
open access

Initiating value‐based healthcare in psoriasis : proposing a value‐based outcome set for daily clinical practice

Niels Hilhorst (UGent) , Elfie Deprez (UGent) , Deepak Mukesh Wieshwaykumar Balak, Nanja van Geel (UGent) , Jan Gutermuth, Isabelle Hoorens (UGent) and Jo Lambert (UGent)

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(3). p.528-539

Academic Bibliography

prof. dr. Nanja van Geel

Exploring the severity strata of disease activity and repigmentation in vitiligo based on validated Physician Global Assessment (PGA) scores

SA-VES : a valid, reliable and feasible tool to assess patient perspective on vitiligo extent

Beyond visual inspection : the value of infrared thermography in skin diseases, a scoping review

A meta-analysis of the placebo response in vitiligo : causes and consequences for the interpretation of clinical trials

The impact of antioxidants on vitiligo and melasma : a scoping review and meta-analysis

Exploring immune checkpoint proteins : novel targets in vitiligo research

A meta-analysis of chemokines in vitiligo : recruiting immune cells towards melanocytes

Clinician‐reported outcome measures for the assessment of vitiligo : a scoping review

Prognostic value of the vitiligo disease activity signs

Initiating value‐based healthcare in psoriasis : proposing a value‐based outcome set for daily clinical practice

Contents

Support

Contact